Cargando…
Pentraxin-3 Predicts Long-Term Cardiac Events in Patients with Chronic Heart Failure
The aim of this study was to investigate the long-term prognostic value of pentraxin-3 (PTX3) in patients with chronic heart failure (CHF). 377 patients were prospectively followed up for 3 years to determine cardiac events including cardiac death or rehospitalization for worsening heart failure. Th...
Autores principales: | Liu, Haibo, Guo, Xiaofang, Yao, Kang, Wang, Chunming, Chen, Guozhong, Gao, Wei, Yuan, Jie, Yu, Wangjun, Ge, Junbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4633533/ https://www.ncbi.nlm.nih.gov/pubmed/26579541 http://dx.doi.org/10.1155/2015/817615 |
Ejemplares similares
-
Prognostic Value of Plasma Pentraxin-3 Levels in Patients with Stable Coronary Artery Disease after Drug-Eluting Stent Implantation
por: Haibo, Liu, et al.
Publicado: (2014) -
Characterizing a long-term chronic heart failure model by transcriptomic alterations and monitoring of cardiac remodeling
por: Zhu, Yingqi, et al.
Publicado: (2021) -
Association Between Cystatin C and Cardiac Function and Long-Term Prognosis in Patients with Chronic Heart Failure
por: Wu, Xilin, et al.
Publicado: (2020) -
The Utility of Pentraxin and Modified Prognostic Scales in Predicting Outcomes of Patients with End-Stage Heart Failure
por: Szczurek-Wasilewicz, Wioletta, et al.
Publicado: (2022) -
Pathogen Recognition by the Long Pentraxin PTX3
por: Moalli, Federica, et al.
Publicado: (2011)